Varicella-zoster virus is considered to have one of the most stable genomes of all human herpesviruses. In 1998, we reported the unanticipated discovery of a wild-type virus that had lost an immunodominant B-cell epitope on the gE ectodomain (VZV-MSP); the gE escape mutant virus exhibited an unusual pattern of egress. Further studies have now documented a markedly enhanced cell-to-cell spread by the mutant virus in cell culture. This property was investigated by laser scanning confocal microscopy combined with a software program that allows the measurement of pixel intensity of the fluorescent signal. For this new application of imaging technology, the VZV immediate early protein 62 (IE 62) was selected as the fluoresceinated marker. By 48 h postinfection, the number of IE 62-positive pixels in the VZV-MSP-infected culture was nearly fourfold greater than the number of pixels in a culture infected with a low-passage laboratory strain. Titrations by infectious center assays supported the above image analysis data. Confirmatory studies in the SCID-hu mouse documented that VZV-MSP spread more rapidly than other VZV strains in human fetal skin implants. Generally, the cytopathology and vesicle formation produced by other strains at 21 days postinfection were demonstrable with VZV-MSP at 14 days. To assess whether additional genes were contributing to the unusual VZV-MSP phenotype, ϳ20 kb of the VZV-MSP genome was sequenced, including ORFs 31 (gB), 37 (gH), 47, 60 (gL), 61, 62 (IE 62), 66, 67 (gI), and 68 (gE). Except for a few polymorphisms, as well as the previously discovered mutation within gE, the nucleotide sequences within most open reading frames were identical to the prototype VZV-Dumas strain. In short, VZV-MSP represents a novel variant virus with a distinguishable phenotype demonstrable in both infected cell cultures and SCID-hu mice.
INTRODUCTION
Based on their extensive analyses of herpesviral molecular evolutionary history, McGeoch and Davison (1999) estimate that herpesvirus DNA sequences mutate 10-100 times faster than the equivalent classes of sequences on the host genome. For glycoprotein gB, a highly conserved open reading frame (ORF) among all herpesviruses, they calculate that nonsynonymous substitutions have occurred at a rate of 2.7 ϫ 10 Ϫ8 substitutions per site per year and synonymous substitutions at 10 Ϫ7 substitutions per site per year (McGeoch and Davison, 1999) . McGeoch and Davison (1999) also provide convincing arguments in favor of the concept of cospeciation; in other words, herpesvirus lineages arise by way of coevolution with their specific host. In the case of VZV, the progenitor virus most likely arose 60-70 million years before the present (McGeoch and Cook, 1994; McGeoch et al., 1995) .
Of all the human herpesviruses, VZV may undergo the fewest replication cycles during the lifetime of the infected host. Based on a probable schema of pathogenesis, the virus actively replicates for a period of 10-14 days after infection of the human host (Arvin, 1996; Grose, 1999) . During a bout of chickenpox, therefore, VZV has at most 20 replication cycles. Based on our current understanding of VZV latency and reactivation, no further replication occurs unless the individual develops herpes zoster in late adulthood. Because of the above scenario, the genetic stability of the VZV genome has been presumed.
VZV contains the smallest genome of the human herpesviruses, encoding 69 ORFs within the complete VZVDumas sequence (Davison and Scott, 1983) . Of these ORFs, at least 7 code for glycoproteins (Cohen and Straus, 1996; Grose, 1990; Mo et al., 1999) . VZV gE, the product of ORF 68, is the most abundantly produced viral glycoprotein during infection. Unlike other alphaherpesviral homologs, the VZV gE protein is a major antigenic determinant, inducing both cytolytic and humoral responses (Arvin et al., 1986; Bergen et al., 1991; Ito et al., 1985) . VZV gE, in complex with glycoprotein I (gI), acts as a human Fc receptor on the surface of infected cells (Litwin et al., 1990 (Litwin et al., , 1992 . The cytoplasmic tails of both gE and gI contain endocytosis motifs, allowing internalization and recycling of the complex to and from the cell membrane . The gE and gI cytoplasmic tails also are modified by both serine/threonine and tyrosine phosphorylation motifs Yao et al., 1993; Ye et al., 1999) . The fact that gE cannot be deleted suggests that it is essential (Cohen and Seidel, 1993; Mallory et al., 1997) . Because of its important functions, the recent discovery of a VZV gE escape mutant (VZV-MSP) was completely unexpected; based on the prototypic VZV-Dumas sequence, the mutant gE protein contains a D150N substitution (Santos et al., 1998) . The current report provides a more complete characterization of the altered biological properties and genetic composition of this contemporary variant in VZV evolution. For the first time, we have discovered a VZV variant virus which has a cell-to-cell spread phenotype clearly distinguishable from that of previously characterized VZV strains.
RESULTS
Cell-to-cell spread phenotype of VZV-MSP During our initial assessment of VZV-MSP, we observed that the egress of VZV-MSP particles in cell culture differed from that of other typical VZV laboratory strains, such as VZV-32 and VZV-Oka (Santos et al., 1998) . Like other VZV strains, however, infectious virus was not released into the culture medium. The fact that greater numbers of VZV-MSP particles were present on the surface suggested that cell-to-cell spread may be increased. Cell-to-cell spread has been assessed in both HSV-1 and PRV through measurement of plaque size in permissive cells or the number of cells infected within a typical plaque (Dingwell et al., 1994; Tirabassi et al., 1997; Tirabassi and Enquist, 1999) . Neither technique is easily applicable in the VZV system given the formation of irregularly shaped syncytia by VZV in cell culture and the absence of cell-free virus in tissue culture. Therefore, we developed a technique to assess cell-to-cell spread through confocal microscopic examination.
We compared the spread of low-passage VZV-MSP to that of the low-passage laboratory strain VZV-32. Human melanoma cells were inoculated with either VZV-32 or VZV-MSP at a 1:8 ratio of infected:uninfected cells. At increasing intervals postinfection, the infected monolayers were probed with an antibody against the VZV immediate early protein 62 (IE 62). The number of cells expressing IE 62 and the intracellular localization of the protein were determined. This assay was based on the observation by Kinchington and Turse (1998) that VZV IE 62 is present in the nuclei of infected cells during early stages of infection, but then appears in the cytoplasm during later stages.
The confocal micrographs in Figs. 1A and 1B compare VZV-32 and VZV-MSP at 4 h postinfection. This time point represents the number of infected cells originally overlaid onto each monolayer. Both panels contained similar levels of IE 62-positive cells. Figures 1C and 1D compare VZV-32 and VZV-MSP at 24 h postinfection. The difference in extent of spread between VZV-MSP and VZV-32 was apparent. Figures 1E and 1F represent a typical focus of infection present in each monolayer when viewed at a higher magnification. For VZV-32 in Fig. 1E , 6-8 cells with advanced infection were present in each focus; IE 62 was present in both nucleus and cytoplasm. A few scattered cells adjacent to the infectious focus contained nuclei with IE 62 concentrated near the membrane; these cells represented a recent transfer of infectivity from the central focus. When the VZV-MSP culture was examined (Fig. 1F) , large syncytia had already formed at 24 h postinfection. A typical syncytium contained 20-30 nuclei, an infectious focus three-to fourfold larger than that seen with VZV-32. This experiment was repeated four times with equivalent results.
Quantitative analysis of confocal images of VZV IE 62
To quantify the difference in cell-to-cell spread, multiple confocal images were analyzed with the image analysis programs called Brainvox tal_support programs (Frank et al., 1997) . Each confocal image is made up of 512 ϫ 512 pixels, for a total of 262, 144 pixels. We analyzed the green fluorescence channel representing the presence of VZV IE 62 within each confocal image. The image analysis program initially assigns a relative signal intensity within each pixel of the confocal image. Then, a threshold of signal intensity is calculated to remove background signals. This analysis facilitated quantitation of all pixels within each confocal image that contained IE 62. Thus, confocal microscopy of IE 62 coupled with image analysis facilitated a comparison of the extent of viral spread between two different VZV strains.
The results for this analysis are shown in Fig. 2 . Note that there was no major difference between the extent of IE 62 spread for VZV-32 and VZV-MSP at 4, 8, and 12 h postinfection. The results at both 4 and 8 h, in particular, demonstrated that each monolayer was infected with a similar inoculum of infected cells. Also, the lack of a difference between the three time points (4-12 h) confirmed that the replication cycle for both VZV strains was greater than 12 h, in agreement with previous studies (Yamanishi et al., 1980) . However, at 24 h postinfection, there was a noticeable difference between the spread of VZV-MSP and VZV-32. The extent of VZV-MSP spread was at least twofold greater than that of VZV-32. At 48 h postinfection, this difference increased further, as the VZV-MSP spread was fourfold greater than that of VZV-32. Thus, image analysis provided a new method by which to measure differences in cell-to-cell spread be-tween VZV strains. Again, this methodology is particularly suited for VZV because cell-free virus is not released spontaneously from infected cell cultures; even after sonic disruption of infected monolayers, most viral particles remain attached to remnants of outer cellular membranes (Grose and Brunell, 1978; Weller, 1953) . 
VZV infectious center assays
Because the results in the previous experiments represented a new application of confocal microscopy, we turned to a traditional method to confirm the differences in VZV cell-to-cell spread, namely, infectious center assays (Cole and Kingsley, 1992; Grose and Brunell, 1978) . For these titrations, the initial virus inocula were replicate samples of VZV-infected cells frozen and stored in liquid nitrogen. After being frozen, 1 aliquot was thawed and titrated from each lot. The inoculum for each 35-mm tissue culture dish was 500 infectious centers. Two dishes were harvested and assayed at each of the following time points: immediately after inoculation (0 h) and 24 and 48 h postinoculation (Fig. 3) . When comparing the average fold increase of VZV-MSP infectious centers to VZV-32 infectious centers, the spread of VZV-MSP was consistently greater than the spread of VZV-32 over both the first 24-h period (24 h p.i.) and the second 24-h period (48 h p.i.). Otherwise stated, at 48 h postinfection, the cytopathic effect of VZV-MSP was complete, while numerous infectious center titrations with VZV-32 demonstrated that a 60-to 72-h interval was required for similar spread (Grose and Brunell, 1978) . Furthermore, the rapidity of VZV-32 spread was not altered over the initial 20 passages. (VZV-Oka and VZV-Ellen titrations exhibit a time course similar to that of VZV-32; C. Grose, unpublished observations.) Therefore, results from both quantitative confocal microscopic image analyses and infectious center assays documented that the spread of VZV-MSP was three-to fourfold greater than the spread of VZV-32.
Growth of VZV-MSP in the SCID-hu mouse
The SCID-hu mouse has provided the first reproducible animal model of VZV pathogenesis. Published studies have documented the pathology of viral infection in human thymus/liver and skin implants after inoculation with parental and vaccine Oka strains as well as lowpassage wild-type virus (Moffat et al., 1995 (Moffat et al., , 1998a . To assess whether VZV-MSP showed enhanced pathology in the SCID-hu mouse model, skin implants infected with VZV-MSP were harvested at 7, 14, and 21 days after infection. At 7 days postinfection, numerous foci of infection were visible in the epidermis of the human skin implant (Figs. 4A and 4B) . By 14 days the foci coalesced into large necrotic lesions with histopathology typical of varicella vesicles (Fig. 4C ). These vesicles were characterized by epidermal hyperplasia, balloon cells, and the separation of the keratin roof from the epidermis. After 21 days, the infection had spread into the dermis and destroyed the entire implant (Fig. 5A) . Samples of the implants also were examined by previously described elec-
Quantitative analysis of VZV IE 62 by confocal microscopy. VZV-MSP-or VZV-32-infected monolayers were examined by confocal microscopy at increasing times postinfection at ϫ4 original magnification. The total number of pixels positive for VZV IE 62 within each image was quantitated with the Brainvox tal_support programs (University of Iowa). The graph summarizes the results from four separate images. Error bars: Ϯ1 SD.
FIG. 3.
Infectious center assays of VZV-MSP and VZV-32. Infectious center assays were carried out by previously described methods (Cole and Kingsley, 1992; Grose and Brunell, 1978) . The numbers of infectious centers present at 24 and 48 h postinfection were determined for VZV-MSP and VZV-32. The average fold increase of infectious centers at each interval was tabulated. tron microscopy methods; the virion formation closely resembled that shown in Fig. 2 of the report by Moffat et al. (1998a) . Mock-infected skin implants showed normal skin structure consisting of a thin layer of keratinocytes above the dermis and hair follicles (Fig. 5B) .
Prior published studies had not shown such a rapid progression of pathology in the SCID-hu mouse infected with VZV (Moffat et al., 1995 (Moffat et al., , 1998a . To further assess this aspect of VZV infection in the animal model, another experiment was performed with a clinical isolate passaged even fewer times than VZV-32; in addition, the low-passage parent VZV-Oka strain was included. Again, the skin samples were collected and examined at days 7, 14, and 21 postinoculation. When all the specimens were reviewed, the histopathology of the clinical isolate and parental VZV-Oka at 21 days postinoculation were similar, and for both strains the histopathology was approaching that caused by VZV-MSP at 14 days postinoculation (Fig. 6 ). Even at 21 days, however, the former two viral strains never caused the total destruction seen after VZV-MSP infection (Fig. 5A) . In short, the progression of VZV-MSP through the skin implant was noticeably more extensive than that seen with other viral strains tested in the SCID-hu animal model (Figs. 4, 5, and 6) .
Genetic analysis of other major glycoproteins of VZV-MSP
After documenting the enhanced cell-to-cell spread of VZV-MSP, we questioned whether mutations were present in ORFs other than gE that may be contributing to this phenotype. Specifically, we analyzed ORFs 31, 37, 60, and 67 coding for VZV gB, gH, gL, and gI, respectively. The ORFs were amplified from the VZV-MSP viral genome and sequenced and then compared to the published VZV-Dumas sequence (Davison and Scott, 1986) . Of interest, neither the gI nor the gL gene contained any nucleotide differences when compared to the nucleotide sequences of VZV-Dumas. Further, the gB sequence was identical to that of VZV-Dumas. However, VZV-MSP gH contained a single point mutation within codon 269 (CCA 3 CTA), converting a proline residue in the predicted VZV-Dumas peptide sequence to a leucine residue in VZV-MSP gH.
Given the presence of mutations within VZV-MSP gE and gH, we performed similar genetic analyses of VZV-32. As expected, VZV-32 lacked the D150N mutation within gE. VZV-32 gH, however, revealed the identical point mutation found within codon 269 of VZV-MSP gH. Thus, the mutation within VZV-MSP gH cannot account for the VZV-MSP cellspread phenotype. VZV-32 contained one additional mutation within ORF 67 (gI) which would lead to a Q5H substitution (CAA 3 CAT). This substitution was within the probable leader sequence of VZV gI and thus would not be present in mature gI (Davison and Scott, 1986) . Altogether, within five major glycoprotein ORFs, VZV-MSP contained two point mutations which caused amino acid substitutions when compared to VZV-Dumas: D150N in gE and P269L in gH (Fig. 7) .
In addition to five ORFs, we sequenced major portions of the 5Ј untranslated regions of ORFs 31, 60, 67, and 68. All regions were identical to VZV-Dumas except for that of ORF 60. The latter region contained four polymorphisms; these ranged from 554 to 1320 nucleotides from the ORF 60 initiation codon (Fig. 7) . It is very unlikely that these polymorphisms will alter the expression of gL since they are located over 500 nucleotides upstream of the gL start site.
Genetic analysis of VZV-MSP regulatory proteins and kinases
Although viral glycoproteins are the most likely candidates for mediating the cell-to-cell spread phenotype of VZV-MSP, we considered the possibility that an alteration in immediate early regulatory events may contribute to this enhanced cell-to-cell spread phenotype. VZV expresses one predominant species, IE 62, which acts as the major regulatory protein for viral gene expression (Perera et al., 1992 (Perera et al., , 1993 Piette et al., 1995; Shiraki and Hyman, 1987) . This protein contains a potent acidic activation domain at its N-terminus and is a component of the virus particle (Kinchington et al., 1992; Perera et al., 1993) . Therefore, we sequenced the IE 62 gene of VZV-MSP, but detected only one silent polymorphism within codon 30 when compared to the Dumas strain (GCG 3 GCC) (Fig. 7) . Thus, the peptide sequence of VZV-MSP IE 62 was identical to the predicted VZV-Dumas sequence. Further, we sequenced the 5Ј untranslated region containing 525 nucleotides and this region was identical to that of VZV-Dumas. In addition, we sequenced the adjacent VZV-MSP ORF 61, which encodes the functional homolog of HSV-1 ICP0 (Moriuchi et al., 1992) . Again, the nucleotide sequence was identical to that of VZV-Dumas. Previous studies have shown that the viral protein kinase VZV ORF 47 can phosphorylate IE 62 (Ng, et al., 1994) . Also, VZV ORF 66 encodes a protein kinase which has been shown to affect the intracellular localization and transactivation function of IE 62 (Kinchington and Turse, 1998; Kinchington et al., 2000) . Based upon these results, we wanted to determine whether mutations in these viral kinases could affect the function of IE 62 within VZV-MSP-infected cells. Therefore, we sequenced both protein kinase genes within the VZV-MSP genome and found both to be identical to the prototype VZVDumas sequence (Fig. 7) . Thus, there was no genetic evidence of polymorphisms within either of two regulatory ORFs or either of two viral protein kinase ORFs. In short, after sequence analysis of over 15% of the VZV-MSP genome, the main impression was a striking similarity with VZV-Dumas except for the notable exceptions mentioned earlier.
DISCUSSION
VZV-MSP represents the first reported antigenic variant of VZV gE or any other virion envelope protein. We have previously characterized the effect of the MSP mutation within gE (D150N) on the epitope of the anti-gE 3B3 antibody (Santos et al., 1998) . This amino acid substitution greatly reduces the affinity of MAb 3B3 to gE, causing loss of antibody recognition under normal conditions in both immunofluorescence and Western blot assays. We observed that this mutation was identical to a known amino acid substitution caused by antigenic drift in the influenza A hemagglutinin protein and postulated that VZV-MSP is an escape mutant that circumvents the antibody response following VZV infection (SzomolanyiTsuda and Welsh, 1998; Wharton et al., 1989) . We also have previously reported that VZV-MSP has a dramatically different topography of viral egress onto the surface of infected cultured cells compared to VZV-32 and VZVOka. The latter two strains normally emerge in a pattern which we have designated "viral highways" ; also see cover photo of Virology, 249, Sept. 15, 1998). However, VZV-MSP viral particles were more plentiful and more evenly distributed across the entire surface of infected cells in a pattern that was similar to the egress of HSV-1-infected cells (Padilla et al., 1997; Santos et al., 1998) . Taylor-Robinson and Caunt (1972) detailed the spread of VZV in cell culture in 1972. They noted that small foci ("microplaques") were first detected at 2 days postinfection; the foci subsequently enlarged over the next 4-8 days. When Cohen and Straus (1996) reviewed the topic of VZV growth in cultured cells 24 years later, studies during the intervening decades had revealed relatively little new information about viral variants. One problem with assessing differences between strains in VZV spread and infectivity is the cell-associated nature of VZV infection in cultured cells. Numerous investigations over several decades have discovered that attempts to quantitate cell-free virus invariably lead to simultaneous loss of infectivity, possibly due to loss of the viral envelope. Thus, most studies are performed with an inoculum of infected cells rather than cell-free virus.
To circumvent difficulties with virus titration by more traditional assays, we adapted a software program called Brainvox tal_support systems to analyze confocal images of VZV-infected monolayers (Frank et al., 1997) . In confocal microscopic analysis, a laser scans the sample line by line, generating an excitation signal as it passes over fluorophores coupled to the secondary antibody. After this excitation signal enters the photomultiplier tube, each pixel of the digital image is assigned an intensity determined by the amount of fluorescence of that site in the original sample. The range of the gray scale is from 0 to 255 (8 bit). The software program calculated for each VZV confocal image the intensity of the fluorescent signal within each pixel. In general, the background as determined with uninfected cell controls had a pixel intensity of less than 25, while positive cells had a pixel intensity within the 25-255 range. Thereafter, the Brainvox tal_support programs were instructed to extract the positive pixels and plot the data as a histogram representing VZV IE-62-positive cells. Through this quantitative imaging approach, we were able to document an accelerated cell-to-cell spread phenotype of VZV-MSP.
After we had documented two distinct components of the VZV-MSP phenotype (pattern of viral egress and enhanced cell-to-cell spread), we postulated that VZV-MSP would behave differently in the SCID-hu mouse model. VZV has a highly restricted host range and previous attempts to study the virus in a variety of experimental animals did not mimic the symptomatic disease in humans (Arvin, 1996) . By implanting human fetal skin tissue into SCID-hu mice, an animal model was established which allowed VZV replication in differentiated human skin with subsequent formation of vesicular lesions, the hallmark of human clinical disease (Moffat et al., 1995) . These studies documented a correlation between (i) high infectious foci counts, (ii) increased histopathology, and (iii) detectable enveloped virions in the implants (Moffat et al., 1998a) . The morphological features of virions from skin implants closely resemble the complete enveloped virions seen in samples collected from human vesicular fluid; in contrast, samples collected from infected cell cultures rarely show a prototypic enveloped virion but exhibit a spectrum of aberrant particles . In the prior study, enveloped virions were detected in the skin implants 21 days postinfection with wild-type virus but not vaccine Oka virus (Moffat et al., 1998a) . The fact that virus was detected in VZV-MSP-infected implants at 14 days postin-fection in the current study reinforces the correlation recognized in the 1998 study.
Previous studies in SCID-hu mice have demonstrated a reduced virulence of the vaccine strain of VZV-Oka in comparison to the parental VZV-Oka strain (Moffat et al., 1998a) . The pathogenic properties of laboratory generated VZV mutants have also been assessed. In one example, a VZV-ORF 47 deletion mutant replicated efficiently in cultured cells in vitro but could not replicate within differentiated human cells in the SCID-hu model, a result which highlighted the importance of this viral kinase in vivo (Moffat et al., 1998b) . Thus, the SCID-hu model has facilitated the characterization of VZV strains with reduced virulence in differentiated lymphocytes and skin cells. In juxtaposition, we have now documented for the first time in the SCID-hu animal model an accelerated pathogenesis of VZV-MSP over that of other VZV wildtype isolates and laboratory strains.
The phenotype of the VZV gE mutant virus led us to reexamine the data about the role of this glycoprotein in cell-to-cell spread. VZV gE is a 623-amino-acid, type I transmembrane glycoprotein (Davison and Scott, 1986) . Within the VZV system, gE is considered to be an essential glycoprotein (Mallory et al., 1997) . VZV gE forms a heterodimer with gI, a 354-amino-acid, type I transmembrane glycoprotein whose cytoplasmic tail also contains both endocytosis and phosphorylation motifs Olson and Grose, 1998; Zhu et al., 1996) . The gE and gI glycoproteins interact via their ectodomains (Kimura et al., 1997) . Not only is VZV gI required for replication of the virus in Vero cells, but also VZV gI deletion mutants in melanoma cells show a reduced cell-to-cell spread phenotype, highlighting the role of this protein in cell-to-cell spread (Cohen and Nguyen, 1997; Cohen and Seidel, 1993; Mallory et al., 1997) . In addition, VZV gI acts as a chaperone protein and can facilitate the efficient endocytosis and subcellular trafficking of gE lacking its endocytosis motif (Olson and Grose, 1998) . Of interest, gE cannot perform the same function for a disabled gI protein.
The role of gE in mediating cell-to-cell spread has been well studied in both HSV-1 and PRV (Dingwell et al., 1994 (Dingwell et al., , 1995 Dingwell and Johnson, 1998; Tirabassi et al., 1997; Wisner et al., 2000; Zsak et al., 1992) . Deletional mutants of HSV-1 gE and gI exhibit a reduced plaque size phenotype in tissue culture as well as reduced neuronal spread in a rat eye model (Dingwell et al., 1994; Dingwell and Johnson, 1998) . Studies in the PRV system with gE deletional mutants demonstrated a similar reduced spread in tissue culture and a rat eye model (Tirabassi et al., 1997; Zsak et al., 1992) . However, HSV-1 gE mutants which still expressed the gE ectodomain yet lacked the cytoplasmic domain failed to restore cell-tocell spread in tissue culture, but the ectodomain was able to mediate localization of gE to tight junctions between cells (Wisner et al., 2000) . In contrast, similar PRV gE truncation mutants which still expressed the gE ectodomain showed partial restoration of cell-to-cell spread in tissue culture as well as neurotropic spread in the rat visual system similar to wild-type virus (Tirabassi et al., 1997) . Thus, in studies of alphaherpesviruses other than VZV, gE plays a crucial role in cell-to-cell spread, and the gE ectodomain alone can mediate some of these functions.
We have now sequenced ϳ20 kb of the VZV-MSP genome, including the ORFs of five glycoproteins, two major VZV regulatory proteins, two viral kinases, and major portions of the 5Ј untranslated regions of these ORFs. After evaluating these sequence data, we were struck by the overall identity of VZV-MSP to the prototype VZV-Dumas. Although a few polymorphisms were noted, the majority of these were in untranslated regions (Fig.  7) . Other than the previously reported change within VZV-MSP gE, only one polymorphism (within VZV-MSP gH) led to a predicted amino acid substitution. Within the VZV system the gH:gL complex subsumes a prominent role in fusion (Duus et al., 1995; Rodriguez et al., 1993) . In contrast to HSV-1, monolayers transfected with only the VZV gH and VZV gL genes are completely fused (Duus et al., 1995; Duus and Grose, 1996; Turner et al., 1998 ). Yet, it appeared unlikely that the one-point mutation at position 269 within gH contributed to the VZV-MSP phenotype because the same mutation was found in gH of the laboratory strain VZV-32. In summary, the above data have strengthened the original observation that the variant virus has a phenotype clearly distinguishable from any VZV strain previously studied by the authors of this article.
MATERIALS AND METHODS
Cells, viruses, and transfer of infectivity VZV-MSP was isolated in Minnesota in late 1995 (Santos et al., 1998) . VZV-32 was isolated in Texas in the 1970s (Grose and Brunell, 1978) . Reserve stocks of VZV-32 and VZV-MSP were prepared; thus low passages (Ͻ20) were used in all experiments in this report. VZVOka was isolated in Japan and attenuated in the 1970s (Takahashi et al., 1975) . VZV-Dumas was isolated in Holland and sequenced in its entirety by Davison and Scott (1986) . All strains were propagated in human melanoma cells (MeWo strain). MeWo cells are highly permissive for VZV replication with no release of infectious virus into the culture medium (Grose, 1980) . Transfer of infectivity was carried out by inoculation of trypsin-dispersed infected cells onto an uninfected monolayer at a 1:8 ratio of infected:uninfected cells unless otherwise noted (Grose and Brunell, 1978) . Similarly, infectious center assays were carried out by described methods; these assays included both melanoma cell and human neonatal foreskin cell substrates (Cole and Kingsley, 1992; Grose and Brunell, 1978) .
Imaging by confocal microscopy
Replicate 35-mm monolayers of MeWo cells were overlaid with VZV-infected cells at a 1:8 ratio of infected: uninfected cells. At 4, 8, 12, 24 , and 48 h postinfection, the monolayers were fixed and permeabilized with 0.5 ml of 2% paraformaldehyde with 0.05% Triton X-100. Cells were probed with an anti-IE-62 mouse monoclonal ascites (MAb 5C6) at a dilution of 1:1000 (Ng et al., 1994) . The secondary antibody was goat anti-mouse IgG F(abЈ) 2 conjugated to Alexa 488 at a dilution of 1:2500 (Molecular Probes). Cell nuclei were stained with TOTO-3 (Molecular Probes), a dimeric cyanine nucleic acid stain, at a dilution of 1:10,000. Samples were examined with a Bio-Rad 1024 laser scanning confocal microscope, as described (Duus et al., 1995) .
Quantitative analysis of confocal images
Confocal images were converted to TIFF format images (Confocal Assistant, v. 4.02 ) and transferred to a Silicon Graphics Indy workstation in order to produce the color prints by Showcase software program. Confocal images also were analyzed with the Brainvox tal_support programs (Frank et al., 1997) . Similar analyses can be performed with the public domain NIH Image program, which was developed at the U.S. National Institutes of Health (http://rsb.info.nih.gov/nih-image/).
Replication in the SCID-hu mouse
The SCID-hu mouse has been established as an animal model for VZV replication (Moffat et al., 1995) . In this model, C.B-17 scid/scid mice were implanted with fetal skin tissue subcutaneously as full-thickness dermal grafts. Human fetal tissues were obtained with informed consent according to federal and state regulations and were screened for human immunodeficiency virus. The general care of the experimental animals used for this study was in accordance with the National Institutes of Health guidelines for laboratory animals and in compliance with the Animal Welfare Act (Public Law 94-279) as well as the Stanford University Administrative Panel on Laboratory Animal Care. Animal inoculations were performed according to the previously described protocol (Moffat et al., 1995) , viz., an aliquot of infected cell suspension containing 10 5 infectious centers was injected into each implant. Mock-infected implants were injected with human cells alone. Skin implants were harvested at 7, 14, and 21 days postinoculation. The implants were fixed in 4% paraformaldehyde, paraffin-embedded, cut into 3-m sections, and stained with hematoxylin and eosin. Tissue sections were examined on a Leitz Diaplan light microscope, and digital images were acquired with an Optronics DEI 750 digital camera (Optronics Engineering). Digital images were formatted as described above.
Isolation of viral DNA
For all viral strains, a 25-cm 2 monolayer of MeWo cells was infected as described above. After development of 80-100% cytopathology, the infected monolayer was washed thrice with 0.5 ml of 0.01 M phosphate-buffered saline (PBS), pH 7.4. Infected cells were then harvested by dislodging into 0.5 ml of PBS. Viral DNA was collected with a DNAeasy kit following the Blood and Body Fluid Protocol (Qiagen, Inc.). Following the DNAeasy protocol, DNA was placed onto a Microcon 50 filter (Millipore) and washed twice with 0.5 ml of Nanopure water (Barnstead/ Thermolyne). Viral DNA was resuspended in 100 L of Nanopure water. DNA concentration was assessed visually after 1% agarose gel electrophoresis.
PCR amplification and sequencing of VZV genes
For each ORF, a pair of flanking primers was designed to amplify the gene of interest. PCR amplifications were performed with the Expand High-Fidelity PCR system (Boehringer Mannheim). This system utilizes both Taq DNA and Pwo DNA polymerases, with the 3Ј-5Ј proofreading activity of Pwo DNA polymerase allowing increased fidelity (8.5 ϫ 10 Ϫ6 /bp error rate) (Boehringer Mannheim). After amplification, the PCR product was sequenced by using the dye terminator cycle sequencing chemistry with AmpliTaq DNA polymerase, FS enzyme (Perkin-Elmer Applied Biosystems, Foster City, CA). Sequencing reactions were performed on and analyzed with an Applied Biosystems Model 373A stretch fluorescent automated sequencer (Perkin-Elmer) at the University of Iowa DNA facility. All genes were PCR amplified twice and each PCR fragment was sequenced at least twice to confirm reported mutations. The accession number for the complete VZV-Dumas sequence is X04370.
GenBank deposition
The genomic sequences of VZV-MSP described in the Results were submitted to GenBank, Bethesda, Maryland. The accession numbers for the six viral DNA segments are AY005330, AY005331, AY005332, AY005333, AY005334 and AY005335.
